Year : 2011 | Volume
: 20 | Issue : 2 | Page : 83--90
The neuropsychiatric aspects of influenza/swine flu: A selective review
Narayana Manjunatha1, Suresh Bada Math2, Girish Baburao Kulkarni3, Santosh Kumar Chaturvedi2,
1 Department of Psychiatry, MS Ramaiah Medical College, Bangalore, Karnataka, India
2 Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bangalore, Karnataka, India
3 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bangalore, Karnataka, India
Department of Psychiatry,MS Ramaiah Medical College, Bangalore - 560 054, Karnataka
The world witnessed the influenza virus during the seasonal epidemics and pandemics. The current strain of H1N1 (swine flu) pandemic is believed to be the legacy of the influenza pandemic (1918-19). The influenza virus has been implicated in many neuropsychiatric disorders. In view of the recent pandemic, it would be interesting to review the neuropsychiatric aspects of influenza, specifically swine flu. Author used popular search engine «SQ»PUBMED«SQ» to search for published articles with different MeSH terms using Boolean operator (AND). Among these, a selective review of the published literature was done. Acute manifestations of swine flu varied from behavioral changes, fear of misdiagnosis during outbreak, neurological features like seizures, encephalopathy, encephalitis, transverse myelitis, aseptic meningitis, multiple sclerosis, and Guillian-Barre Syndrome. Among the chronic manifestations, schizophrenia, Parkinson«SQ»s disease, mood disorder, dementia, and mental retardation have been hypothesized. Further research is required to understand the etiological hypothesis of the chronic manifestations of influenza. The author urges neuroscientists around the world to make use of the current swine flu pandemic as an opportunity for further research.
|How to cite this article:|
Manjunatha N, Math SB, Kulkarni GB, Chaturvedi SK. The neuropsychiatric aspects of influenza/swine flu: A selective review.Ind Psychiatry J 2011;20:83-90
|How to cite this URL:|
Manjunatha N, Math SB, Kulkarni GB, Chaturvedi SK. The neuropsychiatric aspects of influenza/swine flu: A selective review. Ind Psychiatry J [serial online] 2011 [cited 2022 Dec 7 ];20:83-90
Available from: https://www.industrialpsychiatry.org/text.asp?2011/20/2/83/102479
Influenza is a viral infectious disease commonly referred as 'flu'. Influenza viruses are RNA viruses and belong to the family 'orthomyxoviridae' with three genera: Influenza Virus A, Influenza Virus B and Influenza Virus C.  Among these, Type A is the most virulent human pathogen and causes the most severe form of the disease. This genus has one species, influenza A virus. The wild aquatic birds are the natural hosts for a large varieties of influenza A. Occasionally, viruses are transmitted to other species and may cause devastating outbreaks in domestic poultry or human influenza pandemics.  Influenza A is further sub-typed into 16 distinct H types and 9 distinct N types based on hemagglutinin and neuraminidase antigens on the surface of the virus.  The confirmed serotypes (in order of deaths) in human pandemics are: H1N1 (caused Spanish flu-1918 and swine-flu-2009), H2N2 (Asian Flu-1957), H3N2 (Hong Kong Flu-1968), H5N1 (highly pathogenic avian influenza virus; there is a threat of the pandemic now), H7N7 and others. 
The recent swine origin of the influenza virus (H1N1 strain) underwent triple reassortment and contains genes from avian, swine and human viruses.  It is believed to be a legacy of the influenza pandemic (1918-19) and has now acquired the ability to infect and spread within the human host after adapting over the last 91 years. 
Influenza usually causes an acute and self-limiting febrile illness but may cause severe complications in medical conditions  and has the potential of significant morbidity in the community.  The most common symptoms of influenza are chills, fever, sore throat, muscle pains, severe headache, coughing, weakness/fatigue and general discomfort.  In serious cases, influenza may cause pneumonia which can be fatal in the young, and particularly in the elderly. Although it is often confused with other influenza-like illnesses, especially with common cold, it is a much more severe disease than common cold. 
Seasonal influenza occurs every year. The Center for Disease Control and Prevention (CDC) reported the first identified cases of respiratory infection with H1N1 virus in the United States on 15 and 17 April, 2009.  On 11 June, 2009, the World Health Organization (WHO) declared the first pandemic of the 21st century by swine flu (H1N1).  The clinical features of hospitalized swine flu cases were generally similar with the seasonal influenza. ,
Neuropsychiatry of Influenza and Swine Flu
Karl A. Menniger was the first researcher to link influenza with neuropsychiatry in 100 influenza patients admitted with behavioral changes in Boston between 15 September and 15 December 1918 (Spanish flu).  This pandemic was also linked with Parkinsonism. 
The influenza virus most commonly affects the respiratory system, but the burden in neuropsychiatric diseases are under-recognized.  Hence a selective review was carried out on the neuropsychiatric aspects of human influenza and especially of the current swine flu pandemic which may helpful for prevention, early recognition and treatment. From the point of view of research this review of the swine flu pandemic may provide some opportunity for future research of many neuropsychiatric disorders. 
The aim of the paper is to do an educational review to sensitize the neuropsychiatric community about the implication of the swine flu pandemic in their clinical practice and discuss the implication for further research.
The authors conducted an electronic search of articles published in 'Pubmed' from 1950 to March 2010. The MeSH terms such as "Influenza, Human" [Mesh] were combined with various terms using Boolean operator (AND). The first author (NM) also screened the cross-references of major articles, and reviews, whenever relevant. The author found a wide scatter of published articles. To arrive at a meaningful discussion, only relevant articles were selected (selective review) based on relevance and hierarchy of scientific evidence.
The hierarchy followed in this review was prospective studies, retrospective studies, systematic reviews, case series followed by case reports (from higher to lower level of evidence) in human beings. Whenever findings from a higher level of evidence are reviewed, similar findings from a lower level of evidence are not repeated in this review. When there was no evidence from human beings, we considered findings from animal studies (taken from cross-references).
Results and Discussion
The neuropsychiatric aspects of influenza/swine flu, for convenience of discussion, are classified into clinical manifestations-related and treatment-related. The clinical manifestations-related aspects were further subdivided into acute (within six months) and chronic (more than six months) manifestations. Treatment-related neuropsychiatric aspects were further subdivided into neuropsychiatric aspects of medication used and of its vaccination. A brief note on the pathogenesis of neuropsychiatric aspects of influenza is also discussed at the end.
Acute Neuropsychiatric Manifestations of Influenza and Present Swine Flu Pandemic
The reports of influenza-associated acute neurological syndromes are available from 1385 onwards. ,, Acute neurological manifestations have been reported during epidemics and are often consistent with serious sequelae or death. An increased incidence of influenza-associated encephalitis/encephalopathy (IAE) has been reported in Japan, mainly in children. Other acute clinical neurological manifestations include seizures, Reye's Syndrome (RS), acute necrotizing encephalopathy, transverse myelitis, and aseptic meningitis as well as autoimmune conditions, such as Guillian-Barre Syndrome (GBS), which may occur during the course of influenza infection. ,,,,, There is evidence that influenza can directly lead to acute encephalitis.  In recent times, a range from mild encephalitis to motor disturbances to coma has been reported with H5N1 infections in poultry  and in humans. 
In a retrospective chart review, Maricich et al., reported a range of neurologic complications such as seizures (n-4), mental status changes (n-3), and mutism (n-1) with seasonal influenza A in eight admitted unimmunized US children (age 5 months to 9 years) in 2003. Investigations revealed the presence of influenza A viral antigen in nasal wash samples (in all patients), isolation of influenza A virus from the cerebrospinal fluid (in only one), and no serum metabolic or cerebrospinal fluid abnormalities (in all). Abnormalities in brain imaging were found in three patients. Among these eight patients, six survived with complete recovery and two of them had sequelae.
Toovey  (in review) found that febrile seizure was the most common clinical presentation in influenza (occurrence is one in five children with complete recovery but has increased risk of subsequent afebrile seizure), whereas, IAE was less common but potentially life-threatening (more in Japan). They also found that clinical manifestations were diverse, typically involving febrile seizures and abnormal behaviors (in mild cases), with rapid evolution through decreased consciousness to coma (in severe forms) and the prognosis was often poor (in serious cases), with outcomes including death or severe neurological sequelae. Toovey  also found that influenza was also known to trigger a number of rarely encountered, but often serious central nervous system (CNS) diseases like encephalopathy of RS, a peripheral neuropathy of GBS, and the lesser known Kleine-Levin syndrome and post-encephalitic Parkinson's disease. Sivadon-Tardy et al., found the serological evidence for influenza viruses playing a role during outbreaks of GBS . In a 30-year study, Kazmierski et al.,  supported the hypothesis that influenza infection could precipitate the onset of multiple sclerosis (MS). De Keyser et al., reported that 33% and 5% of exacerbations in 180 patients with relapsing MS was associated with influenza illness and post-influenza vaccination respectively.
There are case reports of acute psychosis following influenza. , A case report describes an ischemic stroke in a four-year-old male associated with acute influenza A infection. 
Present swine flu pandemic
The acute manifestations of swine flu are simply the behavioral reactions, misdiagnosis/over-treatment and other acute neurological manifestations. In a nationwide cross-sectional telephonic survey of 997 adult citizens of England, Scotland, and Wales after swine flu was declared as pandemic, Rubin et al.,  found significant behavioral changes (as precautionary measures) such as following 'some recommended behavior' (increases in hand washing and surface cleaning or plans made with a "flu friend") in about 38% of participants over the past four days, and nearly 5% carried out 'some avoidance behavior' (engaged in one or more of six behaviors such as avoiding large crowds or public transport). These behavioral changes were correlated with a high level of anxiety.  There is a report of misdiagnosis at the height of the fear of the swine flu pandemic even for a case of sore throat and prescribed unnecessary oseltamivir by health professionals.  There is a report of bizarre neuropsychiatric behavioral changes in one adolescent with novel H1N1. 
For the first time, the neurological complications due to H1N1 were reported on 24 July 2009 from US Center for Disease Control and Prevention (CDC).  These cases presented as encephalopathy (defined operationally as altered sensorium lasting for >24 h) in four children confirmed in nasopharyngeal swabs with enzyme immunoassay method. These four patients, aged 7 to 17 years, were admitted with signs of influenza-like illness and neurological complications. i.e., two had seizures (on third day) and three had abnormal electroencephalograph recordings. H1N1 virus was detected in the nasopharyngeal specimens in all cases but not in the cerebrospinal fluid (CSF). There was complete recovery without any neurologic sequelae in all four patients at the time of discharge. These findings confirmed that, similar to seasonal influenza, the neurologic complications can also occur with novel H1N1 virus after respiratory tract infection, but severity is lesser than that seen in seasonal influenza. This report called for participation of the Neurology community in the surveillance of the current swine flu pandemic for possible involvement of the central nervous system (CNS). 
Chronic Neuropsychiatric Manifestations of Influenza and Swine Flu
A significant numbers of papers from long times demonstrated interest in the chronic manifestations of the influenza virus. The viral hypothesis of influenza has been proposed for many neuropsychiatric disorders, particularly in schizophrenia, Parkinson's disease, Alzheimer's disease and mental retardation.  However, the evidence for this influenza hypothesis is available from animal studies and retrospective human studies with presumptive causation.
The earlier linkage of Parkinsonism with influenza infection was reported after the 1918 influenza pandemic with observation that a number of people are shown diminished mobility and other neurological symptoms suggestive of Parkinson's disease (PD).  Subsequent evidence is also available for this linkage from epidemiological data , and findings of the presence of Type A influenza antigens in Encephalitis lethargica (EL) patients.  The lack of viral RNA from brains of post-encephalic Parkinsonian patients  and the absence of any known mutations of direct infection  are the major drawbacks in the understanding the role of influenza as a Parkinsonian agent.
In a recently published animal study by Jang et al.,  elevated levels of alpha-synuclein, loss of 17% dopaminergic neurons in the substantia nigra and persistent inflammation in areas of the brain infected with H5N1 influenza strain have been reported. All experimental mice developed tremors and movement difficulties suggestive of PD. However, there is no report of PD in human survivors of the H5N1 flu so far and it is too early to know whether those infected are at an increased risk as only a few years have passed since the report of the first cases. Researchers also acknowledge that 70% or more loss of dopaminergic neurons is required for full-blown PD to manifest and the observed 17% reduction in dopaminergic neurons alone may not be sufficient to cause PD, but it may make the brain more susceptible, especially in combination with other factors such as genetic, other environmental triggers, or simply old age. Miller  believes that bird flu may trigger PD in this pandemic as there is a possibility of fear of pandemic with H5N1 serotype). With these evidences, there is a possibility of recurrence of EL in this influenza pandemic.  In view of the reemergence of the highly pathogenic virus Avian influenza A (H5N1) in 2003,  authors call for long-term follow-up studies among survivors of H5N1-infected individuals if it occurs as a pandemic before concluding that it is the causative agent for PD.
Karl A. Menninger first reported "mental disturbances" in 80 patients of influenza admitted in a psychiatric hospital, of whom 16 were diagnosed with delirium, 25 with dementia praecox, 23 with "other types of psychosis," and 16 who could not be classified.  He considered that the Spanish pandemic of influenza (1918) could have led to the development of dementia praecox, but neither he nor his contemporaries raised the possibility of influenza as an etiological agent for schizophrenia that could occur in utero.
In subsequent studies, a high prevalence of schizophrenia was documented in children born in winter and early spring that witness influenza infections.  There are controversial reports on the influenza virus in the etiology of schizophrenia from population-based, retrospective studies ,, with ecological design (i.e., the information on actual individual exposure was not available) that might have led to high false-positives.  Approximately 50% of studies have reported positive associations among 25 incidence studies of schizophrenia in the offspring of women who were thought to have contracted influenza during pregnancy.  The reliability of the documentation of exposure about maternal influenza in these studies are questionable as it is generally based on self-reports of participants or on occurrences of influenza epidemics contemporaneous with their pregnancies. To counter this problem, Brown et al., analyzed influenza antibodies in a case-control study in a population-based birth cohort (in sera drawn from pregnant women whose children later developed schizophrenia, and compared with a matched control group of women whose children did not develop schizophrenia) and found a dramatic sevenfold increase in the risk of schizophrenia among the offspring of women who were exposed to influenza during their first trimester of pregnancy, but not during the second and third trimester. The data collected from actually infected pregnant women in two studies have found no increase in risk of schizophrenia among their children. , Polymerase chain reaction-based studies in pregnant women have not detected influenza virus-specific nucleic acid sequences in brain tissue or CSF. , These evidences along with indirect evidence from animal studies suggest that human influenza viruses may have caused inherent immunological distortions in mind. 
Despite these evidences in the scientific literature for more than a century, there is no conclusive evidence for the influenza/viral etiology of schizophrenia.  Researchers advised to do further studies to get answer for many unanswered viral etiology of schizophrenia in this pandemic , as the data from pregnant women has started available in this pandemic. 
Dementia and mental retardation
Nabeshima et al.,  reported a case of progressive dementia and prolonged gait disturbance after initial presentation of delirium correlated with serologically confirmed influenza A/H3N2 infection in a 91-year-old female patient. Increased risk of mental retardation (MR) was observed in adulthood in children of prenatal exposure to Hong Kong flu  during the winter of 1969-70 especially in third to fourth month of gestation.  Jancar  also observed an association of influenza with MR.
Mood disorders: Depression
A retrospective Australian study with participation of 2514 adolescents/young adults reported an increased prevalence of suicidal and depressive symptoms in people who were born during flu peak in the Southern hemisphere, in comparison with those born in the Northern hemisphere,  but a prospective study by influenza antibody titer disapproved this correlation. 
Mood disorders: Mania
A case of mania induced by influenza B infection has been reported with hypothesis of connection between the locus ceruleus and influenza virus.  Steinberg et al., also reported a manic psychosis in influenza.
Mood disorders: Bipolar disorder vs. Unipolar disorder
In comparison with bipolar disorder, a case-control study found that the risk of occurrence of uniploar affective disorders is increased in people who were exposed to an influenza epidemic during the second trimester which supports the neuro-developmental hypothesis of affective disorder. 
However, Morgan et al.,  found no increased incidence of schizophrenia, affective psychoses and neurotic depression, but a possible effect was found for MR in males exposed in the first and second gestational trimester.
Neuropsychiatric Aspects of Influenza and Swine Flu Treatment (Tamiflu)
Oseltamivir, a neuraminidase inhibitor, is the most commonly used and generally well tolerated medication for swine flu worldwide and encouraging results have been observed if treated within 48 h of detection.  Oseltamivir (Tamiflu) is effective for treating both seasonal flu and H1N1 infection.
Behavioral problems such as jumping and falling from balconies has been reported in young Japanese patients treated with oseltamivir;  that lead authorities to issue warning against the prescription of oseltamivir.  A case of oseltamivir-induced mania was reported in an 18-year-old Chinese lady who was admitted for H1N1 in Hong Kong with family history of bipolar disorder.  There is also a report of oseltamivir-induced delirium in a geriatric patient. 
In an internet-based cross-sectional survey,  18% of oseltamivir-treated H1N1 UK schoolchildren had mild neuropsychiatric side-effects and reported one or more following symptoms: poor concentration/unable to think clearly, problems in sleeping, feeling dazed/confused, bad dreams/nightmares, and behaving strangely.
In post-marketing surveillance of tamiflu, the following transient neuropsychiatric adverse effects were reported mainly from Japan: delusions, hallucinations, sleep problems, abnormal behavior leading to injury, convulsions, encephalitis and delirium to suicide (mainly documented in teenagers). , US Food and Drug Administration (FDA) suggested that the increased reports of neuropsychiatric events in Japanese children are most likely related to an increased awareness of influenza-associated encephalopathy, increased access to Tamiflu in that population, and a coincident period of intensive monitoring of adverse events.  These prompted the inclusion of precautions to the US product label for oseltamivir. 
A retrospective cohort study  funded by Roche (who make Tamiflu) noted a higher rate of episodic mood disorders among those aged 17 years and below receiving oseltamivir compared to those who received no antiviral treatment.
There are many etiological mechanisms are proposed for neuropsychiatric side-effects of oseltamivir. Izumi et al., hypothesized that oseltamivir carboxylase, the main metabolite of oseltamivir, has an effect on the CNS with a role in CNS development and impulse conduction. Yoshino et al., found that oseltamivir increases the release of dopamine in the medial prefrontal cortex and may be the cause of abnormal behavior in young patients.
The genetic mechanism in the Japanese population may be responsible for the neuropsychiatric side-effects with oseltamivir including suicide.  Clinicians are asked to closely monitor this potential side-effect of suicide in every patient, especially with a positive family or personal history of mental illness.
Neuropsychiatry of influenza and oseltamivir: Overall vs. treated vs. untreated
Controversy exists regarding whether neuropsychiatric manifestations are a result of influenza per se or side-effects of oseltamivir. A retrospective cohort study of influenza in 1 to 21 years from USA found that there was no evidence of increased risk of adverse neuropsychiatric outcomes among the study population treated with oseltamivir for influenza. 
Neuropsychiatric Aspects of Vaccination for Influenza and Swine Flu
There are many reports of GBS (subacute/chronic, progressive, post-vaccination encephalopathy) identical to the subacute and chronic forms of polyradiculoneuropathy (very rarely) and subclinical myelopathies (a very few cases of) following vaccination for influenza.  Among all these, GBS is a highly controversial side-effect in view of earlier reports of GBS due to influenza infection itself.
Probably for the first time, occurrence of GBS with vaccine for influenza outbreak was reported in 1976 during a large-scale immunization campaign in New Jersey, USA which led to a cessation of this mass immunization. An estimate suggests that there was a risk of one additional case of GBS per 100,000 people vaccinated for influenza in comparison with background prevalence of GBS of 1-2·3 per 100,000 in the general population. 'Lancet Neurology'  observes that the chances of detecting cases of GBS during the development phase are low since the number of participants in most clinical trials of vaccines against H1N1 is unlikely to exceed 1500. In view of reports of mass vaccination in this swine flu pandemic, the timely reporting and analysis of any neurological complications during the immunization period will be essential.
However, preliminary data from CDC  (1 October- 24 November 2009) suggests that there are no substantial differences noted between H1N1 and seasonal influenza vaccines in the proportion or types of serious adverse events reported after FDA gave license for H1N1 vaccines on 15 September 2009. In light of the H1N1 pandemic, the WHO recommends continuation of surveillance of acute flaccid paralysis that may represent a useful means of monitoring GBS during the pandemic.  In view of controversy of whether GBS is a part of influenza, or a side-effect of influenza vaccination and absence of clear evidence for either, WHO recommended collaborative active surveillance for GBS during immunization which might give better insight about the controversial etiology of GBS.
Pathogenesis of Neuropsychiatric Involvement in Swine Flu
The pathogenesis of swine flu in the respiratory system is beyond the scope of this article and is dealt with elsewhere. 
The evidences for the involvement of the brain in the pathogenesis of influenza virus are available from animal studies. A study of the immunization of rabbits with certain H1N1 influenza viruses led to production of autoantibodies to a brain-specific protein of 37kDa, present in various species including humans.  These autoantibodies were produced only in the brain and not in other tissues. These antibodies were not elicited by other Influenza A or B viruses. In histological studies, the reaction with antiviral antisera was specific to gray matter and was confined to sera that recognized the 37-kDa protein. The binding of the antibody was prominent in regions comprising neuronal cell bodies in cellular layers of the dentate gyrus, hippocampus, cerebral cortex, and cerebellum and not detectable in myelin-rich regions, such as the corpus callosum. The 37-kDa protein, therefore, appears to be a neuronal antigen. Antibodies directed against this protein may be involved in the pathogenesis of one or more of the neuropsychiatric disorders that occur after infection with influenza. 
The well-documented acute neuropsychiatric manifestations of influenza and swine flu are encephalitis/encephalopathy, seizures, RS, transverse myelitis, and aseptic meningitis, and GBS. Among the chronic manifestations of influenza, the evidence for schizophrenia and PD require further scientific data. Suicide and GBS are the two controversial neuropsychiatric side-effects of oseltamivir and influenza vaccination respectively, undergoing post-marketing surveillance.
Many notable neuropsychiatric manifestations implicated with the infection of influenza/swine flu, the relation between swine flu and neuropsychiatry are yet to be understood fully, especially the chronic manifestations. The neuropsychiatric community around the world shall make use this swine flu pandemic for further research.
|1||Dolin R. Influenza. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrisson′s principles of internal medicine. 16 th ed. New York: McGraw Hill; 2005. p. 1066-70.|
|2||Klenk H, Matrosovich M, Stech J. Avian Influenza: Molecular Mechanisms of Pathogenesis and Host Range. In: Mettenleiter TC, editor. Animal Viruses: Molecular Biology. Norfolk: Caister Academic Press; 2008. p. 253-303.|
|3||Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med 2009;361:225-9.|
|4||Smith GJ, Bahl J, Vijaykrishna D, Zhang J, Poon LL, Chen H, et al. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 2009;106:11709-12. |
|5||Newman AP, Reisdorf E, Beinemann J, Uyeki TM, Balish A, Shu B, et al. Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerg Infect Dis 2008;14:1470-2.|
|6||Newman DW, Treanor JJ, Menegus MA. Clinical and laboratory diagnosis of influenza virus infections. Am J Manag Care 2000;6(5 Suppl):S265-75.|
|7||Sebastian MR, Lodha R, Kabra SK. Swine Origin Influenza (Swine Flu). Indian J Pediatr 2009;76:833-41. |
|8||Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-17.|
|9||Eccles, R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005;5:718-25|
|10||Centers for Disease Control and Prevention (CDC). Swine influenza. A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-2.|
|11||Chang LY, Shih SR, Shao PL, Huang DT, Huang LM. Novel swine-origin influenza virus A (H1N1): The first pandemic of the 21st century. J Formos Med Assoc 2009;108:526-32. |
|12||Cowling BJ, Chan KH, Fang VJ, Lau LL, So HC, Fung RO, et al. Comparative epidemiology of pandemic and seasonal Influenza A in households. N Engl J Med 2010;362:2175-84.|
|13||Louria DB, Blumenfield HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959;38:213-65.|
|14||Menninger KA. Psychoses associated with influenza, I: General data: Statistical analysis. JAMA 1919;72:235-41.|
|15||Taubenberger JK. The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc 2006;150:86-112.|
|16||Toovey S. Influenza-associated central nervous system dysfunction: A literature review. Travel Med Infect Dis 2008;6:114-24.|
|17||Manjunatha N. The current swine flu pandemic may provide some opportunity for future research of schizophrenia. Indian J Med Res 2010;132:108-9.|
|18||Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta 2009;1792:714-21. |
|19||Maurizi CP. Why was the 1918 influenza pandemic so lethal? The possible role of a neurovirulent neuraminidase. Med Hypotheses 1985;16:1-5. |
|20||Ravenholt RT, Foege WH. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 1982;2:860-4.|
|21||Maricich SM, Neul JL, Lotze TE, Cazacu AC, Uyeki TM, Demmler GJ, et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics 2004;114:e626-33.|
|22||Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003;28:225-32.|
|23||Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002;35:512-7. |
|24||Fujimoto S, Kobayashi M, Uemura O, Iwasa M, Ando T, Katoh T, et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet 1998;352:873-5.|
|25||Wang YH, Huang YC, Chang LY, Kao HT, Lin PY, Huang CG, et al. Clinical characteristics of children with influenza A virus infection requiring hospitalization. J Microbiol Immunol Infect 2003;36:111-6.|
|26||Hayase Y, Tobita K. Influenza virus and neurological diseases. Psychiatry Clin Neurosci 1997;51:181-4. |
|27||Drago L, Attia MW, DePiero A, Bean C. Influenza A-associated meningoencephalitis. Pediatr Emerg Care 2005;21:437-9. |
|28||Tanimura N, Tsukamoto K, Okamatsu M, Mase M, Imada T, Nakamura K, et al. Pathology of fatal highly pathogenic H5N1 avian influenza virus infection in large-billed crows (Corvus macrorhynchos) during the 2004 outbreak in Japan. Vet Pathol 2006;43:500-9.|
|29||de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005;352:686-91.|
|30||Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis 2009;48:48-56.|
|31||KaŸmierski R, Wender M, Guzik P, Zielonka D. Association of influenza incidence with multiple sclerosis onset. Folia Neuropathol 2004;42:19-23.|
|32||De Keyser J, Zwanikken C, Boon M. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 1998;159:51-3.|
|33||Masson A. Post-influenza acute psychosis in an old man. Ann Med Psychol (Paris) 1957;115:490-4. |
|34||Still RM. Psychosis following Asian influenza in Barbados. Lancet 1958;2:20-1.|
|35||Bell ML, Buchhalter JR. Influenza A-associated stroke in a 4-year-old male. Pediatr Neurol 2004;31:56-8.|
|36||Rubin GJ, Amlôt R, Page L, Wessely S. Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: Cross sectional telephone survey. BMJ 2009;339:b2651. |
|37||Kahr V, Barrett NA, Shankar-Hari M, Slack H, Preston RL, Fhogartaigh CN, et al. A life-threatening sore throat masquerading as swine flu. Lancet 2010;375:524.|
|38||German-Diaz M, Pavo-Garcia R, Diaz-Diaz J, Giangaspro-Corradi E, Negreira-Cepeda S. Adolescent with neuropsychiatric symptoms associated with novel influenza a (H1N1) virus infection. Pediatr Infect Dis J 2010;29:570-1.|
|39||Centers for Disease Control and Prevention (CDC). Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009;58:773-8. |
|40||Pandemic influenza: A priority for the neurological community. Lancet Neurol 2009;8:869. |
|41||Mattson MP. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 2004;3:105-20.|
|42||Gamboa ET, Wolf A, Yahr MD, Harter DH, Duffy PE, Barden H, et al. Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence. Arch Neurol 1974;31:228-32.|
|43||McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol 2001;60:696-704. |
|44||Hansen MK, Nguyen KT, Goehler LE, Gaykema RP, Fleshner M, Maier SF, et al. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton Neurosci 2000;85:119-26. |
|45||Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y,Webster R, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A 2009;106:14063-8. |
|46||Miller G. Bird flu virus a possible trigger for Parkinson′s. 2. Science NOW (Daily News) 2009:2. Available from: http://news.sciencemag.org/scincenow/2009/08/10-12. html. [Last accessed on 2010 May 3].|
|47||McCall S, Vilensky JA, Gilman S, Taubenberger JK. The relationship between encephalitis lethargica and influenza: A critical analysis. J Neurovirol 2008;14:177-85.|
|48||Melidou A. Avian influenza A(H5N1)--current situation. Euro Surveill 2009;14. pii: 19199.|
|49||Battle YL, Martin BC, Dorfman JH, Miller LS. Seasonality and infectious disease in schizophrenia: The birth hypothesis revisited. J Psychiatr Res 1999;33:501-9.|
|50||Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189-92. |
|51||Elder AG, O′Donnell B, McCruden EA, Symington IS, Carman WF. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: Results of serum testing and questionnaire. BMJ 1996;313:1241-2. |
|52||Barr CE, Mednick SA, Munk-Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry 1990;47:869-74. |
|53||Crow TJ. Prenatal exposure to influenza as a cause of schizophrenia: There are inconsistencies and contradictions in the evidence. Br J Psychiatry 1994;164:588-92. |
|54||Bagalkote H, Pang D, Jones PB. Maternal influenza and schizophrenia in the offspring. Int J Ment Health 2001;29:3-21.|
|55||Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61:774-80.|
|56||Crow TJ, Done DJ. Prenatal exposure to influenza does not cause schizophrenia. Br J Psychiatry 1992;161:390-3. |
|57||Cannon M, Cotter D, Coffey VP, Sham PC, Takei N, Larkin C, et al. Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: A follow-up study. Br J Psychiatry 1996;168:368-71. |
|58||Sierra-Honigmann AM, Carbone KM, Yolken RH. Polymerase chain reaction (PCR) search for viral nucleic acid sequences in schizophrenia. Br J Psychiatry 1995;166:55-60. |
|59||Taller AM, Asher DM, Pomeroy KL, Eldadah BA, Godec MS, Falkai PG, et al. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. Arch Gen Psychiatry 1996;53:32-40.|
|60||Brown AS, Derkits EJ. Prenatal infection and schizophrenia: A review of epidemiologic and translational studies. Am J Psychiatry 2010;167:261-80.|
|61||Yudofsky SC. Contracting schizophrenia lessons from the Influenza epidemic of 1918-1919. JAMA 2009;301:324-6.|
|62||Menninger KA. Influenza and schizophrenia. An analysis of post-influenzal "dementia precox," as of 1918, and five years later further studies of the psychiatric aspects of influenza. 1926. Am J Psychiatry 1994;151(6 Suppl):182-7.|
|63||Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA 2010;303:1517-25.|
|64||Nabeshima A, Ikematsu H, Yamaga S, Nakagawa M, Umezaki T, Hara H, et al. A case of an elderly patient with dementia and gait disturbance associated with influenza. Kansenshogaku Zasshi 1997;71:944-8.|
|65||Eriksen W, Sundet JM, Tambs K. Register data suggest lower intelligence in men born the year after flu pandemic. Ann Neurol 2009;66:284-9.|
|66||Takei N, Murray G, O′Callaghan E, Sham PC, Glover G, Murray RM. Prenatal exposure to influenza epidemics and risk of mental retardation. Eur Arch Psychiatry Clin Neurosci 1995;245:255-9.|
|67||Jancar J. Mental handicap and the pandemic influenza. Br J Psychiatry 1994;165:696-7. |
|68||Joiner TE, Pfaff JJ, Acres JG, Johnson F. Birth month and suicidal and depressive symptoms in Australians born in the Southern vs. the Northern hemisphere. Psychiatry Res 2002;112:89-92. |
|69||Sinanan K, Hillary I. Post-influenzal depression. Br J Psychiatry 1981;138:131-3. |
|70||Maurizi CP. Influenza and mania: A possible connection with the locus ceruleus. South Med J 1985;78:207-9.|
|71||Steinberg D, Hirsch SR, Marston SD, Reynolds K, Sutton RN. Influenza infection causing manic psychosis. Br J Psychiatry 1972;120:531-5.|
|72||Machón RA, Mednick SA, Huttunen MO. Adult major affective disorder after prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1997;54:322-8.|
|73||Morgan V, Castle D, Page A, Fazio S, Gurrin L, Burton P, et al. Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: No evidence of a major effect. Schizophr Res 1997;26:25-39.|
|74||Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-50.|
|75||Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: A comprehensive review. Drug Saf 2008;31:1097-114.|
|76||Yoshino T, Nisijima K, Shioda K, Yui K, Kato S. Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex. Neurosci Lett 2008;438:67-9. |
|77||Ho LN, Chung JP, Choy KL. Oseltamivir-induced mania in a patient with H1N1. Am J Psychiatry 2010;167:350.|
|78||Kohen I. Oseltamivir-induced delirium in a geriatric patient. Int J Geriatr Psychiatry 2007;22:935-6. |
|79||Kitching A, Roche A, Balasegaram S, Heathcock R, Maguire H. Oseltamivir adherence and side effects among children in three London schools affected by influenza A (H1N1), May 2009 - an internet-based cross-sectional survey. Euro Surveill 2009;14:19287.|
|80||US Food and Drug Administration (FDA). FDA MedWatch: 2008 Safety Alerts for Human Medical Products (Drugs, Biologics, Medical Devices, Special Nutritionals, and Cosmetics): Tamiflu (oseltamivir phosphate). Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm095044.htm. [2008 Apr 3; Last cited on 2009 May 22].|
|81||US Food and Drug Administration (FDA). Tamiflu Pediatric Adverse Events: Questions and Answers. Available from: http://www.fda.gov/Cder/Drug/infopage/tamiflu/QA20051117.htm. [2005 Nov 17; Last cited on 2009 May 22].|
|82||Smith JR, Sacks S. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Int J Clin Pract 2009;63:596-605.|
|83||Izumi Y, Tokuda K, O′Dell KA, Zorumski CF, Narahashi T. Neuroexcitatory actions of Tamiflu and its carboxylate metabolite. Neurosci Lett 2007;426:54-8. |
|84||Casscells SW, Granger E, Kress AM, Linton A. The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza. Int J Adolesc Med Health 2009;21:79-89.|
|85||Poser CM. Neurological complications of swine influenza vaccination. Acta Neurol Scand 1982;66:413-31. |
|86||Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1351-6.|
|87||Landaverde JM, Danovaro-Holliday MC, Trumbo SP, Pacis-Tirso CL, Ruiz-Matus C. Guillain-Barré syndrome in children aged <15 years in Latin America and the Caribbean: Baseline rates in the context of the influenza A (H1N1) pandemic. J Infect Dis 2010;201:746-50.|
|88||Laing P, Knight JG, Hill JM, Harris AG, Oxford JS, Webster RG, et al. Influenza viruses induce autoantibodies to a brain-specific 37 kDa protein in rabbit. Proc Nati Acad Sci USA 1989;86:1998-2002.|